Companion Animal Healthcare

Global Companion Animal Healthcare Market to Reach US$153.9 Billion by 2030

The global market for Companion Animal Healthcare estimated at US$103.4 Billion in the year 2024, is expected to reach US$153.9 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Veterinary Services, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$95.8 Billion by the end of the analysis period. Growth in the Pharmaceuticals segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.2 Billion While China is Forecast to Grow at 10.9% CAGR

The Companion Animal Healthcare market in the U.S. is estimated at US$28.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$32.3 Billion by the year 2030 trailing a CAGR of 10.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Companion Animal Healthcare Market – Key Trends & Drivers Summarized

Why Is the Companion Animal Healthcare Market Experiencing Rapid Growth?

The rising global pet population has significantly impacted the companion animal healthcare market, with pet owners increasingly prioritizing the well-being of their pets. The trend of pet humanization has fueled a surge in veterinary visits, preventive care, and demand for specialized treatments. Pet owners are more willing than ever to invest in high-quality healthcare services, including vaccinations, diagnostic screenings, and regular check-ups. Furthermore, chronic diseases such as obesity, diabetes, and arthritis are becoming prevalent among pets, necessitating advanced treatment and long-term healthcare management solutions. The pet insurance sector has also seen exponential growth, particularly in North America and Europe, where an increasing number of pet owners are opting for policies that cover routine veterinary care as well as unexpected medical expenses. This shift has enabled greater access to premium healthcare services for companion animals, further propelling market expansion. Additionally, the increasing awareness surrounding zoonotic diseases and the role of veterinary care in preventing disease transmission between animals and humans has encouraged regulatory bodies to promote routine veterinary check-ups, vaccinations, and preventive treatments, further boosting demand for companion animal healthcare services.

How Is Technology Transforming Companion Animal Healthcare?

Technology is revolutionizing the companion animal healthcare sector, leading to the development of more efficient and advanced treatment solutions. One of the most significant innovations in this space is the rise of digital veterinary care, including telemedicine and AI-powered diagnostics. Telehealth services are enabling pet owners to consult veterinarians remotely, reducing the need for in-clinic visits and ensuring prompt medical attention. AI-based diagnostic tools have also enhanced early disease detection, allowing veterinarians to diagnose conditions with greater accuracy and efficiency. Another major advancement is the emergence of personalized pet medicine. Genetic testing and precision medicine are gaining traction in veterinary healthcare, allowing for tailored treatment plans based on an animal`s genetic makeup, breed predisposition, and medical history. This approach is particularly beneficial in the treatment of hereditary diseases and chronic conditions, ensuring optimized treatment regimens for individual animals. Additionally, wearable pet health monitoring devices, such as smart collars and biosensors, are providing real-time health data, enabling early intervention and continuous health tracking. The pharmaceutical segment is also evolving, with veterinary drug manufacturers developing novel biologics, vaccines, and extended-release medications that offer improved efficacy with reduced dosing frequency. The integration of biotechnology and nanomedicine is further enhancing drug delivery mechanisms, improving absorption, and minimizing side effects. These innovations are collectively driving efficiency and effectiveness in companion animal healthcare, contributing to the overall growth of the market.

What Are the Emerging Market Trends Shaping the Industry?

The increasing demand for premium pet healthcare services is shaping the industry`s growth trajectory, particularly in developed regions where pet owners are seeking holistic wellness solutions. Veterinary clinics and hospitals are expanding their service offerings to include advanced imaging technologies, dental care, rehabilitation therapy, and alternative treatments such as acupuncture and physiotherapy. These services, once considered niche, are now becoming mainstream due to growing consumer awareness and preference for integrative healthcare approaches. E-commerce has also emerged as a game-changer in the companion animal healthcare market. The convenience of online pet pharmacies, subscription-based pet wellness plans, and direct-to-consumer veterinary products has led to increased accessibility of high-quality medications, supplements, and nutritional products. The growing penetration of online platforms has facilitated seamless purchasing experiences for pet owners, encouraging compliance with regular healthcare regimens. Additionally, the rising trend of organic and natural pet healthcare products is gaining momentum, with pet owners actively seeking chemical-free alternatives for flea and tick prevention, skincare, and dietary supplements. Regulatory advancements are another critical factor influencing market dynamics. Governments and veterinary organizations worldwide are implementing stricter guidelines for pet healthcare, ensuring the safety and efficacy of animal pharmaceuticals, medical devices, and vaccines. Additionally, the rise in regulatory approvals for novel veterinary drugs and biologics is expanding the treatment landscape, allowing veterinarians access to cutting-edge therapeutic options. As a result, veterinary healthcare providers and pharmaceutical companies are focusing on innovation to align with evolving regulations and consumer expectations.

What Are the Key Growth Drivers Fueling the Market?

The growth in the companion animal healthcare market is driven by several factors, including the rising incidence of pet diseases, increasing pet ownership, and the expansion of veterinary infrastructure. One of the primary drivers is the surge in chronic health conditions among pets, necessitating the development of advanced treatment protocols and continuous healthcare monitoring. As pet longevity increases, the need for specialized geriatric veterinary care is also growing, further driving demand for targeted healthcare solutions. The expansion of veterinary services and pet healthcare facilities in emerging markets is playing a crucial role in market growth. Developing regions in Asia-Pacific, Latin America, and the Middle East are witnessing heightened investments in veterinary hospitals, diagnostic centers, and pet wellness clinics. The increasing availability of professional veterinary services, coupled with rising disposable incomes, is encouraging pet owners in these regions to invest more in their pets` health. Additionally, the growing penetration of pet insurance policies in these regions is further enhancing access to quality veterinary care. Another significant growth driver is the increasing consumer preference for preventive veterinary care. Pet owners are becoming more proactive in scheduling routine veterinary check-ups, vaccinations, dental cleanings, and nutritional counseling. This shift toward preventive healthcare is leading to higher adoption rates of diagnostic tools, wellness programs, and pet health supplements. The integration of data-driven insights in veterinary care is also allowing for more personalized and effective treatment plans, aligning with evolving consumer expectations. The rapid advancements in veterinary pharmaceuticals and biotechnology are creating new opportunities for market expansion. The growing investment in veterinary drug research and development, coupled with the rise of regenerative medicine, gene therapy, and biologics, is revolutionizing the treatment landscape for companion animals. As innovation continues to drive the industry, the companion animal healthcare market is poised for sustained growth, with increasing adoption of technology-driven healthcare solutions and evolving consumer preferences shaping its future trajectory.

SCOPE OF STUDY:

The report analyzes the Companion Animal Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Veterinary Services, Pharmaceuticals, Medical Devices); Animal Type (Dogs, Cats, Horses, Other Animal Types); Distribution Channel (Pharmacies Distribution Channel, Distributors Distribution Channel, E-commerce Distribution Channel)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• Agrolabo S.p.A.
• Aratana Therapeutics (now part of Elanco)
• Bayer AG
• bioMérieux
• Boehringer Ingelheim GmbH
• Ceva Santé Animale S.A.
• Dechra Pharmaceuticals PLC
• Elanco Animal Health
• FUJIFILM Corporation
• Heska Corporation
• IDEXX Laboratories, Inc.
• Mars Petcare
• Merck & Co., Inc.
• Neogen Corporation
• SeQuent Scientific Limited
• Thermo Fisher Scientific Inc.
• Vetbiolix
• Vetoquinol S.A.
• Virbac S.A.
• Zoetis Services LLC
• Zymox (Pet King Brands)

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.